In a series of four papers, published in Nature Biotechnology and Nature Communications, an international group of scientists led by CeMM’s Principal Investigator Christoph Bock and Stephan Beck (University College London, UCL) have marked the feasibility of epigenetic analysis for clinical diagnostics and precision medicine.